Apollo Hospitals Enterprise Limited offers healthcare products, medical services, and digital health solutions. This 43-year-old power company is now managed by Dr. Prathap C. Reddy (Founder and Chairman), Dr. Suneeta Raddy (Managing Director), Preetha Reddyand Shobana Kamineni (Executive Vice Chairpersons) along with 62,000 plus employees. The company has experienced an 88.2% growth in its share price over the last five years. However, their revenue is 25,228 crore, and their net Income is 1,941 crore for FY 2026.

Establishment:

1983 in Chennai, Tamil Nadu, India

Website:

https://www.apollohospitals.com

Company Listed On:

Bombay Stock Exchange (BSE) and National Stock Exchange of India (NSE)

Core Business:

Apollo Hospitals Enterprise Limited provides healthcare products, medical services, and digital health solutions.

Financial Performance:

Apollo Hospitals has shown strong financial growth, with revenue and net profit increasing over the years. However, their revenue is 25,228 crore, and their net income is 1,941 crore for FY 2026.

Future Outlook:

1. They are providing quality healthcare services
2. They are focused on advanced medical technology
3. They are receiving treatment using advanced medical equipment
4. They are increasing hospital capacity and expanding diagnostic services

Disclaimer:

Unsold 70 publishes research-based articles, blogs, news, and company profiles to help readers understand businesses along with their future prospects. It will help you learn about the stock market and mutual funds. We research the companies as per our algorithm and find companies that need further research. However, the Apollo Hospitals Enterprise Ltd company profile is not an investment recommendation, as past performance does not guarantee future results. You should perform your own research and seek advice from a SEBI-registered financial advisor before making investment decisions. Visit our Super 70 page to know about the best companies in terms of future growth. It will help you to take up the companies for further research.